Navigation Links
Pressure BioSciences' Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
Date:7/18/2012

SOUTH EASTON, Mass., July 18, 2012 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that multiple research reports have cited the ability of the Company's Pressure Cycling Technology ("PCT") Platform to improve the detection of RNA, DNA, and/or protein in forensic, environmental, and biodefense applications, and in research studies focused on the discovery of biomarkers of disease.  These studies were conducted in laboratories worldwide, including:

  • Institute of Forensic Sciences (Beijing, China) where scientists concluded that PCT was one of the most effective methods available for extracting DNA from bone in forensic applications.  These findings extend earlier studies by other forensic scientists that PCT could lead to better methods of identification of crime victims and bodies of missing persons.
  • Lawrence Berkeley National Laboratory (Berkeley, CA) where scientists studying the Deepwater Horizon oil spill in the Gulf of Mexico used PCT to increase cell lysis efficiency.  Studies such as this are important in the assessment of the impact of oil spills on the environment.
  • Cernomics Solutions (Frederick, MD) where scientists concluded that PCT sterilized and extracted complex, mixed matrix biological samples better than other pre-analytical sample preparation methods available today.  Improved methods for safe and effective sample preparation are essential for rapid and robust identification of highly infectious potential bioterror agents, and also to enable better basic research underlying solutions discovery and development.
  • Harvard School of Public Health (Boston, MA) where scientists demonstrated that PCT could achieve superior recovery of membrane-associated proteins with more than a 20-fold increase in throughput and with improved reproducibility.  The improvement in the recovery of membrane proteins is bel
    '/>"/>

SOURCE Pressure BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Failure to Take Medicine Linked to Unnecessary Hospital Visits, Especially for Medicare Patients Taking High Blood Pressure or High Cholesterol Medications
3. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
4. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
5. Negative Pressure Wound Therapy (NPWT) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
6. Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
8. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
9. Neurocrine Biosciences Reports First Quarter 2012 Results
10. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
11. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ... and audio webcast to discuss financial results for the second ... July 31, 2014 at 4:30 p.m. ET. ... July 31, 2014 Time: 4:30 PM ET Listen via Internet: ... A webcast replay will be available on the ...
(Date:7/28/2014)... July 28, 2014  Dignity Health St. Mary,s ... the Get With The Guidelines®-Stroke Silver-Plus Quality Achievement ... by the American Heart Association/American Stroke Association for ... number four cause of death and a leading ... United States , according to the American ...
(Date:7/28/2014)... Inc. (NASDAQ: ANTH ), today announced financial results ... 2014. Net loss for the three months ... million for the same period in 2013. The decrease in ... interest expense in the current period.  Net ... $15.2 million, compared with net loss of $15.9 million for ...
Breaking Medicine Technology:Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 2Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 3Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 4Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 5Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 6Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 7
(Date:7/28/2014)... 29, 2014 Treat skin to a true ... Beauty®. , Today and tomorrow only (while supplies last), take ... cleanser is ideal for two specific users: , 1) those ... and bacteria free, and , 2) aging skin to help ... Kathy Heshelow, founder of Sublime Beauty®. , Those with oily ...
(Date:7/28/2014)... blood cell development have spread from Africa into nearly ... new study led by King,s College London. The international ... for the origin of changes in a key regulator ... haemoglobin is normally found in fetuses and infants, but ... to keep making it as adults experience milder symptoms ...
(Date:7/28/2014)... July 29, 2014 A leading proposal ... Security disability trust fund by reallocating payroll taxes has ... poll by The Senior Citizens League (TSCL) . ... shifting revenues from the Social Security retirement trust fund ... fix the disability program’s financing. “TSCL believes this ‘band ...
(Date:7/28/2014)... 29, 2014 NAPW honors ... County Hospital Center, as a 2014 Professional Woman of ... distinction for leadership in community health. As the largest, ... virtually every industry and profession, the National Association of ... with over 600,000 members and nearly 300 Local Chapters. ...
(Date:7/28/2014)... have long known that they monopolize large amounts of ... cells are also characterized by a series of features ... ordered set. Researchers are calling this behavior "mesenchymal," and ... Meylan,s research team was able to demonstrate that the ... result from the same mechanism, at least in ...
Breaking Medicine News(10 mins):Health News:Clear, Clean Skin With the New Salicylic Wash from Sublime Beauty®; Enlivens Skin, Unclogs Pores 2Health News:Study tracks worldwide spread of beneficial blood cell gene variant 2Health News:Study tracks worldwide spread of beneficial blood cell gene variant 3Health News:The Senior Citizens League Finds No Support Among Seniors for Likely Disability Trust Fund Fix 2Health News:The Senior Citizens League Finds No Support Among Seniors for Likely Disability Trust Fund Fix 3Health News:National Association of Professional Women Announces Pamela A. Schulters, Head Nurse at Kings County Hospital Center, a 2014 Professional Woman of the Year 2Health News:Cancer: Tumors absorb sugar for mobility 2
... incidents at the nation’s hospitals rose three percent over ... hospitals had a 40 percent lower rate of medical ... the largest annual study of patient-safety issued today by ... ,The HealthGrades study of 40.56 million Medicare hospitalization ...
... figure out the words' meaning for themselves, research by a ... an undergraduate student in the John Hopkins University and who ... by inference is more powerful for 3-year-olds than just being ... that is particularly exciting about the work Meredith is doing ...
... A homeopathic treatment for cancer is under trial at a ... it would pass muster in the next six months., ... homeopathic medicine have already begun in the United States and ... its efficacy," Dr Susanta K Banerjee, a professor of haematology ...
... the state children’s health insurance program (SCHIP), teens ... eliminated and more preventive care is received. This ... their health care providers about guns, smoking, drugs, ... their long-term health. ,"Adolescents have the ...
... For the first time ever, a team of Toronto ... tests //to screen high-risk pregnant mothers for placental damage. ... be reassured that their placenta is formed and functioning ... tests are done early enough, at 16 to 23 ...
... endogenous pain-inhibitory function and increases spontaneous pain in women//. ... in chronic pain, according to a study published in ... ,The study, conducted by Michael T. Smith, PhD, and ... females, who were studied polysomnographically for seven nights. On ...
Cached Medicine News:Health News:Hospital Errors Rise 3 Percent -- HealthGrades Patient-safety Study 2Health News:Hospital Errors Rise 3 Percent -- HealthGrades Patient-safety Study 3Health News:Learning Words by Inference More Powerful for Toddlers 2Health News:Teens Get Needed Access to Care With State Health Insurance 2Health News:Teens Get Needed Access to Care With State Health Insurance 3Health News:New Placenta Screening for High-risk Pregnancies 2Health News:New Study in SLEEP Finds That Sleep Disturbance Increases Spontaneous Pain in Women 2
Codman periosteal elevators, sharp, length 8" (203 mm), blade width 3/16" (5 mm)....
Langenbeck periosteal elevators, wide, blade width 11/16" (17 mm), length 7 1/2" (191 mm)....
Iowa University periosteal elevator, blade width 11/16" (17 mm), length 7 1/4" (184 mm)....
Cushing-Hopkins periosteal elevator, Gutsch handle, blade width 7/16" (11 mm), length 7 5/8" (194 mm)....
Medicine Products: